MA31953B1 - Nouveaux derives du thiophene. - Google Patents
Nouveaux derives du thiophene.Info
- Publication number
- MA31953B1 MA31953B1 MA32972A MA32972A MA31953B1 MA 31953 B1 MA31953 B1 MA 31953B1 MA 32972 A MA32972 A MA 32972A MA 32972 A MA32972 A MA 32972A MA 31953 B1 MA31953 B1 MA 31953B1
- Authority
- MA
- Morocco
- Prior art keywords
- thiophene
- new derivatives
- preparation
- derivatives
- compounds
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/04—Antineoplastic agents specific for metastasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/14—Drugs for disorders of the endocrine system of the thyroid hormones, e.g. T3, T4
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Public Health (AREA)
- General Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Diabetes (AREA)
- Pulmonology (AREA)
- Endocrinology (AREA)
- Rheumatology (AREA)
- Urology & Nephrology (AREA)
- Hematology (AREA)
- Transplantation (AREA)
- Dermatology (AREA)
- Pain & Pain Management (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Oncology (AREA)
- Emergency Medicine (AREA)
- Gastroenterology & Hepatology (AREA)
- Obesity (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Physical Education & Sports Medicine (AREA)
- Biomedical Technology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Abstract
La présente invention concerne de nouveaux dérivés du thiophène, leur préparation et leur utilisation en tant que composés pharmaceutiquement actifs. Lesdits composés agissent notamment comme agents immunomodulateurs.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IB2007054991 | 2007-12-10 | ||
PCT/IB2008/055156 WO2009074950A2 (fr) | 2007-12-10 | 2008-12-09 | Nouveaux dérivés du thiophène |
Publications (1)
Publication Number | Publication Date |
---|---|
MA31953B1 true MA31953B1 (fr) | 2010-12-01 |
Family
ID=40640372
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MA32972A MA31953B1 (fr) | 2007-12-10 | 2010-06-30 | Nouveaux derives du thiophene. |
Country Status (15)
Country | Link |
---|---|
US (1) | US8148410B2 (fr) |
EP (1) | EP2222667B1 (fr) |
JP (1) | JP5503551B2 (fr) |
KR (1) | KR20100095593A (fr) |
CN (1) | CN101896482B (fr) |
AU (1) | AU2008334297A1 (fr) |
BR (1) | BRPI0820868A2 (fr) |
CA (1) | CA2706834A1 (fr) |
ES (1) | ES2403209T3 (fr) |
IL (1) | IL206221A0 (fr) |
MA (1) | MA31953B1 (fr) |
MX (1) | MX2010005889A (fr) |
RU (1) | RU2010128006A (fr) |
TW (1) | TW200930363A (fr) |
WO (1) | WO2009074950A2 (fr) |
Families Citing this family (41)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
TWI404706B (zh) * | 2006-01-11 | 2013-08-11 | Actelion Pharmaceuticals Ltd | 新穎噻吩衍生物 |
ES2400533T3 (es) * | 2006-09-07 | 2013-04-10 | Actelion Pharmaceuticals Ltd. | Derivados de piridin 4-ilo como agentes inmunomoduladores |
AR061841A1 (es) * | 2006-09-07 | 2008-09-24 | Actelion Pharmaceuticals Ltd | Derivados de tiofen-oxadiazoles, agonistas del receptor s1p1/edg1, composiciones farmaceuticas que los contienen y usos como agentes inmunomoduladores. |
NZ576059A (en) * | 2006-09-08 | 2012-03-30 | Actelion Pharmaceuticals Ltd | Pyridin-3-yl derivatives as immunomodulating agents |
SI2125797T1 (sl) * | 2007-03-16 | 2014-03-31 | Actelion Pharmaceuticals Ltd. | Derivati amino-piridina kot agonisti receptorja s1p1/edg1 |
EP2262799B1 (fr) * | 2008-03-06 | 2012-07-04 | Actelion Pharmaceuticals Ltd. | Composés de pyridine |
BRPI0910288A2 (pt) * | 2008-03-07 | 2019-09-24 | Actelion Pharmaceuticals Ltd | composto de derivados de aminometil benzeno, composição farmacêutica que compreende esse composto e uso do mesmo. |
WO2009109872A1 (fr) * | 2008-03-07 | 2009-09-11 | Actelion Pharmaceuticals Ltd | Dérivés de pyridin-2-yle utilisés comme agents immunomodulateurs |
RU2547098C2 (ru) | 2009-07-16 | 2015-04-10 | Актелион Фармасьютиклз Лтд | Производные пиридин-4-ила |
EP2560969B1 (fr) * | 2010-04-23 | 2015-08-12 | Bristol-Myers Squibb Company | Amides du 4-(5-isoxazolyl or 5-pyrrazolyl-1,2,4-oxadiazol-3-yl)-acide mandelique comme agonistes du sphingosin-1-phosphate 1 recepteur |
US9187437B2 (en) | 2010-09-24 | 2015-11-17 | Bristol-Myers Squibb Company | Substituted oxadiazole compounds |
WO2012098505A1 (fr) | 2011-01-19 | 2012-07-26 | Actelion Pharmaceuticals Ltd | Dérivés de 2-methoxy-pyridin-4-yl |
US9000016B2 (en) * | 2012-11-05 | 2015-04-07 | Allergan, Inc. | 1,3,4-Oxadiazoles-2-thio derivatives as sphingosine-1 phosphate receptors modulators |
SG11201708794PA (en) | 2015-05-20 | 2017-12-28 | Idorsia Pharmaceuticals Ltd | Crystalline form of the compound (s)-3-{4-[5-(2-cyclopentyl-6-methoxy-pyridin-4-yl)-[1,2,4]oxadiazol-3-yl]-2-ethyl-6-methyl-phenoxy}-propane-1,2-diol |
EP3371177A1 (fr) | 2015-11-02 | 2018-09-12 | Basf Se | Utilisation d'oxadiazoles substitués pour lutter contre les champignons phytopathogènes |
EP3165094A1 (fr) | 2015-11-03 | 2017-05-10 | Basf Se | Oxadiazoles substitués pour lutter contre les champignons phytopathogènes |
EP3370525A1 (fr) | 2015-11-04 | 2018-09-12 | Basf Se | Utilisation d'oxadiazoles substitués pour lutter contre les champignons phytopathogènes |
BR112018009566A2 (pt) | 2015-11-13 | 2018-11-06 | Basf Se | compostos, mistura, composição agroquímica, uso de compostos e método para combater fungos nocivos fitopatogênicos |
BR112018009579A2 (pt) | 2015-11-13 | 2018-11-06 | Basf Se | composto da fórmula i, mistura, composição agroquímica, uso de composto e método de combate a fungos |
AU2016355949A1 (en) | 2015-11-19 | 2018-05-10 | Basf Se | Substituted oxadiazoles for combating phytopathogenic fungi |
KR20180083419A (ko) | 2015-11-19 | 2018-07-20 | 바스프 에스이 | 식물병원성 진균을 퇴치하기 위한 치환 옥사디아졸 |
US10986839B2 (en) | 2016-04-11 | 2021-04-27 | Basf Se | Substituted oxadiazoles for combating phytopathogenic fungi |
WO2017211650A1 (fr) | 2016-06-09 | 2017-12-14 | Basf Se | Oxadiazoles substitués pour lutter contre des champignons phytopathogènes |
WO2017211652A1 (fr) | 2016-06-09 | 2017-12-14 | Basf Se | Oxadiazoles substitués pour lutter contre des champignons phytopathogènes |
EP3555056A1 (fr) | 2016-12-19 | 2019-10-23 | Basf Se | Oxadiazoles substitués pour lutter contre des champignons phytopathogènes |
EP3339297A1 (fr) | 2016-12-20 | 2018-06-27 | Basf Se | Oxadiazoles substitués pour lutter contre les champignons phytopathogènes |
EP3585773B1 (fr) | 2017-02-21 | 2021-04-07 | Basf Se | Oxadiazoles substitués pour lutter contre les champignons phytopathogènes |
AU2018247768A1 (en) | 2017-04-07 | 2019-10-03 | Basf Se | Substituted oxadiazoles for combating phytopathogenic fungi |
WO2018188962A1 (fr) | 2017-04-11 | 2018-10-18 | Basf Se | Oxadiazoles substitués utilisés pour lutter contre des champignons phytopathogènes |
WO2018202491A1 (fr) | 2017-05-04 | 2018-11-08 | Basf Se | Trifluorométhyloxadiazoles substitués utilisés pour lutter contre des champignons phytopathogènes |
WO2018219797A1 (fr) | 2017-06-02 | 2018-12-06 | Basf Se | Oxadiazoles substitués utilisés pour lutter contre des champignons phytopathogènes |
EP3642187A1 (fr) | 2017-06-19 | 2020-04-29 | Basf Se | 2-[[5-(trifluorométhyl)-1,2,4-oxadiazol-3-yl]aryloxy](thio)acétamides pour lutter contre des champignons phytopathogènes |
WO2019002158A1 (fr) | 2017-06-30 | 2019-01-03 | Basf Se | Trifluorométhyloxadiazoles substitués utilisés pour lutter contre des champignons phytopathogènes |
WO2019025250A1 (fr) | 2017-08-04 | 2019-02-07 | Basf Se | Trifluorométhyloxadiazoles substitués permettant de lutter contre des champignons phytopathogènes |
WO2019038042A1 (fr) | 2017-08-21 | 2019-02-28 | Basf Se | Trifluorométhyloxadiazoles substitués utilisés pour lutter contre des champignons phytopathogènes |
US11076596B2 (en) | 2017-09-18 | 2021-08-03 | Basf Se | Substituted trifluoromethyloxadiazoles for combating phytopathogenic fungi |
EP3713936B1 (fr) | 2017-11-23 | 2021-10-20 | Basf Se | Trifluorométhyl-oxadiazoles substitués pour lutter contre les champignons phytopathogènes |
US11014940B1 (en) | 2018-10-16 | 2021-05-25 | Celgene Corporation | Thiazolidinone and oxazolidinone compounds and formulations |
US11014897B1 (en) | 2018-10-16 | 2021-05-25 | Celgene Corporation | Solid forms comprising a thiazolidinone compound, compositions and methods of use thereof |
US11186556B1 (en) | 2018-10-16 | 2021-11-30 | Celgene Corporation | Salts of a thiazolidinone compound, solid forms, compositions and methods of use thereof |
US11013723B1 (en) | 2018-10-16 | 2021-05-25 | Celgene Corporation | Solid forms of a thiazolidinone compound, compositions and methods of use thereof |
Family Cites Families (33)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE1092929B (de) | 1959-04-16 | 1960-11-17 | Hoechst Ag | Verfahren zur Herstellung von substituierten Thiophen-2-carbonsaeureestern bzw. den freien Carbonsaeuren |
WO1991015583A1 (fr) | 1990-04-05 | 1991-10-17 | The American National Red Cross | Famille de proteines apparentee a une proteine precoce immediate exprimee par des cellules endotheliales humaines durant la differenciation |
TW414795B (en) | 1996-07-01 | 2000-12-11 | Yamanouchi Pharma Co Ltd | A thiophene derivative and the pharmaceutical composition |
CN1223648A (zh) * | 1996-07-01 | 1999-07-21 | 山之内制药株式会社 | 新颖的噻吩衍生物及其医药组合物 |
JP2002505868A (ja) | 1998-03-09 | 2002-02-26 | スミスクライン・ビーチャム・コーポレイション | ヒトEDG−1cポリヌクレオチドおよびポリペプチドおよびその使用法 |
CN1347411A (zh) * | 1999-04-19 | 2002-05-01 | 盐野义制药株式会社 | 含有噁二唑环的磺酰胺衍生物 |
WO2001083464A1 (fr) * | 2000-04-21 | 2001-11-08 | Shionogi & Co., Ltd. | Derives d'oxadiazole efficaces en matiere de traitement ou de prevention d'etats pathologiques glomerulaire |
CA2406685C (fr) * | 2000-04-21 | 2006-10-31 | Shionogi & Co., Ltd. | Derives d'oxadiazole efficaces en matiere de traitement ou de prevention d'etats pathologiques glomerulaires |
DE60329073D1 (de) | 2002-01-18 | 2009-10-15 | Merck & Co Inc | Edg-rezeptoragonisten |
DE60330047D1 (en) | 2002-01-18 | 2009-12-24 | Merck & Co Inc | "n-(benzyl)aminoalkyl carboxylate, phosphinate, phosphonate und tetrazole als edg rezeptoragonisten" |
AU2003279915A1 (en) | 2002-10-15 | 2004-05-04 | Merck And Co., Inc. | Process for making azetidine-3-carboxylic acid |
CA2539438A1 (fr) * | 2003-10-01 | 2005-04-14 | Merck And Co., Inc. | 1,2,4-oxadiazoles substitues 3,5-aryle, heteroaryle ou cycloalkyle servant d'agonistes du recepteur s1p |
EP1697333A4 (fr) | 2003-12-17 | 2009-07-08 | Merck & Co Inc | Carboxylates propanoiques 3,4-disusbstitues utilises en tant qu'agonistes du recepteur s1p (edg) |
WO2006010379A1 (fr) | 2004-07-29 | 2006-02-02 | Actelion Pharmaceuticals Ltd. | Nouveaux derives du thiophene utilises comme agents immunosupresseurs |
CN101043887A (zh) | 2004-10-22 | 2007-09-26 | 默克公司 | 用作s1p受体激动剂的2-(芳基)氮杂环甲基羧酸酯、磺酸酯、膦酸酯、次膦酸酯和杂环化合物 |
WO2006100635A2 (fr) | 2005-03-23 | 2006-09-28 | Actelion Pharmaceuticals Ltd | Nouveaux derives de thiophene |
US7605269B2 (en) | 2005-03-23 | 2009-10-20 | Actelion Pharmaceuticals Ltd. | Thiophene derivatives as Sphingosine-1-phosphate-1 receptor agonists |
PT1863787E (pt) | 2005-03-23 | 2011-07-29 | Actelion Pharmaceuticals Ltd | Derivados de benzo(c)tiofenos hidrogenados como imunomoduladores |
CN101203512A (zh) | 2005-04-22 | 2008-06-18 | 第一三共株式会社 | 杂环化合物 |
WO2006114400A1 (fr) | 2005-04-26 | 2006-11-02 | Neurosearch A/S | Nouveaux derives d'oxadiazole et usage medical de ceux-ci |
BRPI0612028A2 (pt) | 2005-06-08 | 2010-10-13 | Novartis Ag | oxadiazóis ou isodiazóis policìclicos e uso dos mesmos como ligantes de receptor s1p |
CA2612661A1 (fr) | 2005-06-24 | 2006-12-28 | Actelion Pharmaceuticals Ltd. | Nouveaux derives de thiofene |
CN101203220A (zh) | 2005-06-28 | 2008-06-18 | 阿斯利康(瑞典)有限公司 | 新用途 |
AR057894A1 (es) | 2005-11-23 | 2007-12-26 | Actelion Pharmaceuticals Ltd | Derivados de tiofeno |
TWI404706B (zh) * | 2006-01-11 | 2013-08-11 | Actelion Pharmaceuticals Ltd | 新穎噻吩衍生物 |
JP5063615B2 (ja) | 2006-01-24 | 2012-10-31 | アクテリオン ファーマシューティカルズ リミテッド | 新規ピリジン誘導体 |
GB0601744D0 (en) | 2006-01-27 | 2006-03-08 | Novartis Ag | Organic compounds |
JP2009269819A (ja) | 2006-08-25 | 2009-11-19 | Asahi Kasei Pharma Kk | アミン化合物 |
AR061841A1 (es) | 2006-09-07 | 2008-09-24 | Actelion Pharmaceuticals Ltd | Derivados de tiofen-oxadiazoles, agonistas del receptor s1p1/edg1, composiciones farmaceuticas que los contienen y usos como agentes inmunomoduladores. |
JP2008120794A (ja) * | 2006-10-16 | 2008-05-29 | Daiichi Sankyo Co Ltd | ヘテロ環化合物を含有する医薬組成物 |
BRPI0720043A2 (pt) | 2006-12-15 | 2014-01-07 | Abbott Lab | Composto oxadiazol |
WO2008091967A1 (fr) | 2007-01-26 | 2008-07-31 | Smithkline Beecham Corporation | Composés chimiques |
EP2291080B1 (fr) | 2008-05-14 | 2015-08-19 | The Scripps Research Institute | Nouveaux modulateurs des récepteurs de la sphingosine phosphate |
-
2008
- 2008-12-09 MX MX2010005889A patent/MX2010005889A/es unknown
- 2008-12-09 ES ES08859227T patent/ES2403209T3/es active Active
- 2008-12-09 JP JP2010537572A patent/JP5503551B2/ja not_active Expired - Fee Related
- 2008-12-09 EP EP08859227A patent/EP2222667B1/fr not_active Not-in-force
- 2008-12-09 RU RU2010128006/04A patent/RU2010128006A/ru not_active Application Discontinuation
- 2008-12-09 US US12/747,280 patent/US8148410B2/en not_active Expired - Fee Related
- 2008-12-09 CA CA2706834A patent/CA2706834A1/fr not_active Abandoned
- 2008-12-09 WO PCT/IB2008/055156 patent/WO2009074950A2/fr active Application Filing
- 2008-12-09 TW TW097147938A patent/TW200930363A/zh unknown
- 2008-12-09 BR BRPI0820868A patent/BRPI0820868A2/pt not_active IP Right Cessation
- 2008-12-09 KR KR1020107013025A patent/KR20100095593A/ko not_active Application Discontinuation
- 2008-12-09 AU AU2008334297A patent/AU2008334297A1/en not_active Abandoned
- 2008-12-09 CN CN2008801206875A patent/CN101896482B/zh not_active Expired - Fee Related
-
2010
- 2010-06-07 IL IL206221A patent/IL206221A0/en unknown
- 2010-06-30 MA MA32972A patent/MA31953B1/fr unknown
Also Published As
Publication number | Publication date |
---|---|
US20100261702A1 (en) | 2010-10-14 |
EP2222667A2 (fr) | 2010-09-01 |
IL206221A0 (en) | 2010-12-30 |
EP2222667B1 (fr) | 2013-02-20 |
MX2010005889A (es) | 2010-06-22 |
CA2706834A1 (fr) | 2009-06-18 |
BRPI0820868A2 (pt) | 2019-09-24 |
JP5503551B2 (ja) | 2014-05-28 |
TW200930363A (en) | 2009-07-16 |
CN101896482B (zh) | 2013-01-09 |
KR20100095593A (ko) | 2010-08-31 |
US8148410B2 (en) | 2012-04-03 |
AU2008334297A1 (en) | 2009-06-18 |
RU2010128006A (ru) | 2012-01-20 |
JP2011506423A (ja) | 2011-03-03 |
CN101896482A (zh) | 2010-11-24 |
WO2009074950A2 (fr) | 2009-06-18 |
ES2403209T3 (es) | 2013-05-16 |
WO2009074950A3 (fr) | 2009-08-06 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MA31953B1 (fr) | Nouveaux derives du thiophene. | |
MA31849B1 (fr) | Nouveaux dérivés de pyrimidine | |
MA30765B1 (fr) | Derives innovants du thiophene | |
MA32170B1 (fr) | Nouveaux derives d'aminomethylbenzene | |
MY154909A (en) | Novel thiophene derivatives | |
WO2006100635A3 (fr) | Nouveaux derives de thiophene | |
BRPI0608604B8 (pt) | moduladores de 2,3-dioxigenase de indolamina e composição farmacêutica | |
MA38432A1 (fr) | Nouveaux dérivés d'octahydro-pyrrolo [3,4-c]-pyrrole et analogues de ceux-ci servant d'inhibiteurs d'autotaxine | |
EA201170703A1 (ru) | Производные адамантилбензамида | |
TW200700406A (en) | Novel thiophene derivatives | |
TW200716591A (en) | Novel thiophene derivatives | |
MA30226B1 (fr) | Agents cytotoxiques comprenant de nouveaux derives de tomaymycine et leur utilisation therapeutique. | |
TW200738670A (en) | Novel thiophene derivatives | |
MA32351B1 (fr) | Derives d'aminodihydrothiazine a titre d'inhibiteurs de bace pour le traitement de la maladie d'alzheimer | |
NO20083630L (no) | Nye pyridinderivater | |
MA32729B1 (fr) | Derives d'acide 1-amino-2-cyclobutylethylboronique | |
MA31703B1 (fr) | Dérivés pyridiniques utilisés comme modulateurs du récepteur s1p1/edg1 | |
MA30718B1 (fr) | Derives de pyridin-4-yle en tant qu'agents immunomodulateurs. | |
EA201000642A1 (ru) | 2'-фтор-2'-дезокситетрагидроуридины в качестве ингибиторов цитидиндеаминазы | |
ATE482210T1 (de) | Oxadiazolderivate als s1p1-rezeptor-agonisten | |
CL2010001348A1 (es) | Compuestos derivados de 1-oxo-2,3-dihidro-1h-isoindolin-5-il)-isoxazol-3-carboxamida, potenciadores de los mglur2; composicion farmaceutica; y su uso para aliviar los sintomas o disminuir la aparicion de los sintomas de ezquizofrenia o ansiedad. | |
EA201001680A1 (ru) | Соединения бензолсульфонамидтиазола и оксазола | |
BRPI0513841A (pt) | composto, composição farmacêutica, e uso do composto | |
BRPI0518904A2 (pt) | formulaÇÕes de nepafenac tàpicas | |
EA200901319A1 (ru) | Композиции для назального введения |